NEW DELHI — A team of Swedish researchers has identified biomarkers in the
blood associated with symptoms of long Covid, particularly severe respiratory
disorders.
Long Covid is a condition characterised by persistent
symptoms including acute breathlessness and fatigue, after an infection caused
by the SARS-CoV-2 virus.
The team from Karolinska Institutet discovered a set of
proteins in the blood of people with long Covid. The findings may pave the way
for future diagnosis and treatment.
"The proteins were mainly found in patients with
long Covid and severe respiratory problems," said Marcus Buggert, docent
at the Department of Medicine, Karolinska Institutet.
"This is a biomarker pattern that we know to be
linked to inflammatory signal pathways involved in cell death and lung damage
and that has also been observed in other patient groups with severe pulmonary
disorders," he added.
For the study, the team analysed blood samples from 265
patients in Sweden and the UK, who contracted Covid when no vaccine was yet
available.
Using advanced techniques, the researchers measured
thousands of proteins in the blood plasma, which they related to the patient's
symptoms.
The results, published in the journal Nature Immunology,
exposed the underlying biological processes that can cause certain patients to
experience severe symptoms long after previous Covid-19.
"By identifying the proteins that are elevated in
affected patients, we're creating a platform from which to develop diagnostic
tools and new targeted therapies," Dr. Buggert said. "This is
especially important since there are no specific biomarkers and treatments for
long Covid."
The team next aims to study lung and gastrointestinal
tissue to understand what underpins this pattern.
This will likely enable them to locate the source of the
identified proteins and find if there is any remaining inflammation or tissue
damage in specific organs of patients with long Covid, they said.